Opportunities for US Medical Device and Biotech Companies in the Changing EU Clinical and Regulator

A seminar presented by Elisabeth Liljensten, DDS, PhD, founder and CEO of Swedish CRO DEVICIA, Åsa Runnäs, CEO at Symbioteq a Swedish Regulatory Affairs Consultancy and Tomas Camnell, founder of Symbioteq